| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥33.0B | ¥37.4B | -11.7% |
| Operating Income | ¥-1.9B | ¥-0.1B | -2.9% |
| Ordinary Income | ¥-1.8B | ¥0.3B | -8.6% |
| Net Income | ¥-1.4B | ¥0.1B | -16.8% |
| ROE | -2.0% | 0.2% | - |
FY2026 Q1 results show significant deterioration across all profit metrics. Revenue reached 33.0B yen (YoY -11.7%), marking the first period of contraction. Operating income fell to -1.9B yen (prior year -0.1B yen), widening the loss by 1.8B yen. Ordinary income came in at -1.8B yen (prior year 0.3B yen, YoY -8.6x), and net income declined to -1.4B yen (prior year 0.1B yen, YoY -16.8x). Basic EPS deteriorated to -125.91 yen from 13.10 yen, representing a decline of over 1000%. The company transitions from marginal profitability to substantive losses, driven by revenue contraction combined with elevated fixed cost burden and working capital inefficiencies.
Revenue declined 11.7% YoY to 33.0B yen, reflecting demand weakness or channel adjustments. Cost of sales decreased to 24.3B yen, yielding gross profit of 8.7B yen with a gross margin of 26.3%, representing a 2.3pt improvement from the prior period's implied 24.0% margin. Despite gross margin expansion, SG&A expenses of 10.5B yen consumed 32.0% of revenue, up from 29.6% in the prior year, indicating fixed cost deleverage as sales declined. The absolute SG&A level remained elevated relative to the reduced revenue base, causing operating income to fall into a loss of 1.9B yen from -0.1B yen. Non-operating items contributed marginally, with ordinary income at -1.8B yen versus operating income of -1.9B yen, showing a net positive contribution of approximately 0.1B yen. Income tax expense of -0.4B yen provided partial relief, but net income still reached -1.4B yen. No material extraordinary items are disclosed, suggesting the losses stem from core operational challenges rather than one-time events. This represents a revenue down, profit down pattern, with the decline in profitability outpacing revenue contraction due to operating leverage working in reverse.
[Profitability] ROE deteriorated to -2.0%, down from positive territory in prior periods, reflecting net losses. Operating margin reached -5.6%, a decline from near breakeven levels previously, driven by SG&A deleverage. Net profit margin stood at -4.2%, indicating that every 100 yen of sales generated a 4.2 yen loss. Gross margin of 26.3% improved 2.3pt YoY, suggesting product mix shift or cost reduction at the COGS level, but insufficient to offset SG&A burden. [Cash Quality] Cash and deposits totaled 31.3B yen, providing coverage of 13.6x against short-term debt of 2.3B yen. Working capital reached 50.7B yen with a current ratio of 217.3% and quick ratio of 176.7%, indicating robust short-term liquidity. However, inventories surged to 17.5B yen from 10.7B yen, a 63.2% increase, raising concerns about product turnover and potential obsolescence. [Investment Efficiency] Total asset turnover declined to 0.262, down from healthier levels, with the inventory buildup contributing to asset base expansion while sales contracted. Inventory turnover days extended significantly, indicating substantial working capital trapped in stock. Receivables decreased 30.0% to 24.6B yen, yet receivables turnover days of 272 remain elevated. [Financial Health] Equity ratio stood at 56.8%, down from 56.3%, with total equity of 71.7B yen against total assets of 126.1B yen. Interest-bearing debt remained low at 2.3B yen, yielding a debt-to-equity ratio of 0.03 and debt-to-capital ratio of 3.1%, indicating conservative leverage. Current ratio of 217.3% and net working capital of 50.7B yen provide buffer against near-term obligations, though all short-term debt is classified as current, warranting attention to refinancing needs.
Cash and deposits decreased marginally to 31.3B yen from 31.8B yen, reflecting a decline of 0.5B yen. Despite operating losses, the cash position remains relatively stable, suggesting that working capital movements partially offset earnings deterioration. Inventories increased substantially by 6.8B yen to 17.5B yen, representing a significant cash outflow into working capital. This buildup indicates either production ahead of anticipated demand or sales shortfalls against production plans. Receivables declined 10.5B yen to 24.6B yen, contributing a positive cash inflow as customer collections outpaced new credit sales, likely reflecting the lower revenue run rate. Trade payables decreased from 17.3B yen to 14.6B yen, representing a 2.7B yen outflow as the company paid down supplier obligations. The net working capital effect shows inventory absorption dominating, with inventory increase exceeding receivables collection benefit. Total assets declined 6.6B yen to 126.1B yen, while equity decreased 3.0B yen to 71.7B yen, with the net loss accounting for the majority of equity reduction. Short-term liquidity coverage remains adequate at 13.6x cash-to-short-term-debt, but the rapid inventory accumulation warrants close monitoring of future cash generation and inventory realization.
Ordinary income of -1.8B yen versus operating income of -1.9B yen shows a net non-operating contribution of approximately 0.1B yen. Non-operating income components are minimal at 0.0B yen for interest and dividend income, and non-operating expenses similarly show 0.0B yen for interest expense, indicating negligible financial income or cost impacts. The near-alignment of operating and ordinary income confirms that losses originate from core operations rather than financial activities. Non-operating income represents less than 1% of revenue, indicating earnings are not materially influenced by non-core activities. The absence of cash flow statement data for this quarterly period limits accruals assessment, but balance sheet changes reveal a concerning trend: substantial inventory accumulation without corresponding sales, suggesting potential accrual quality issues if inventory requires write-downs. The 63.2% inventory surge combined with operating losses raises questions about inventory valuation adequacy and whether provision for obsolescence is sufficient. Receivables collection improving while sales decline suggests some cash realization, but extended receivables days of 272 indicate ongoing collection challenges. Overall earnings quality is low, with operating losses, inventory buildup exceeding sales needs, and unclear cash generation from operations pointing to fundamental business headwinds requiring operational restructuring.
Progress rate versus full-year guidance stands at 17.3% for revenue (33.0B yen achieved against 191.0B yen target), -22.6% for operating income (loss of 1.9B yen against profit target of 8.2B yen), -21.8% for ordinary income (loss of 1.8B yen against profit target of 8.3B yen), and -28.0% for net income (loss of 1.4B yen against profit target of 5.0B yen). Standard Q1 progress of 25% suggests revenue is tracking 7.7pt below plan, while all profit metrics show substantial underperformance with negative progress rates due to Q1 losses against positive full-year profit targets. The full-year forecast assumes dramatic sequential improvement, requiring Q2-Q4 to generate cumulative operating income of 10.1B yen to reach the 8.2B yen target. This implies an average quarterly operating profit of approximately 3.4B yen for the remaining three quarters, a significant turnaround from the -1.9B yen Q1 result. Revenue must average 52.7B yen per quarter in Q2-Q4 to achieve the 191.0B yen target, representing 60% growth versus Q1's run rate. Forecast assumptions note that actual results may differ significantly due to factors outside current information, suggesting management acknowledges elevated execution risk. The substantial inventory buildup in Q1 could support higher sales in subsequent quarters if demand materializes, but persistent inventory accumulation would indicate structural demand-supply mismatch. Achievement of full-year guidance depends critically on revenue recovery, SG&A cost control, and inventory normalization in the remaining periods.
Inventory obsolescence and valuation risk: Finished goods inventory surged 63.2% to 17.5B yen while revenue declined 11.7%, creating a significant inventory-to-sales mismatch. Extended inventory turnover days indicate products are not moving at expected rates, raising risk of write-downs or discounted sales that would further erode margins. Work-in-process of 9.7B yen and raw materials of 4.9B yen also contribute to elevated working capital lock-up.
Operating leverage and fixed cost burden: SG&A expenses of 10.5B yen exceeded gross profit of 8.7B yen, driving operating losses. The SG&A-to-sales ratio expanded to 32.0% from 29.6%, indicating fixed costs are not flexing with revenue decline. Continued revenue shortfalls without commensurate cost reduction will perpetuate losses and erode equity.
Full-year guidance execution risk: Q1 progress rates significantly lag plan across all profit metrics, with negative profit realization against positive targets. Achieving the 8.2B yen operating income target requires generating approximately 10B yen in operating profit over Q2-Q4, implying a dramatic business inflection. If demand recovery does not materialize or inventory cannot be monetized efficiently, guidance faces substantial downside risk and potential revision.
[Industry Position] (Reference - Proprietary Analysis)
The company's Q1 performance falls below manufacturing industry medians across most key metrics. Profitability shows ROE of -2.0% versus industry median of 3.1%, operating margin of -5.6% versus median 6.8%, and net profit margin of -4.2% versus median 5.9%, indicating significant underperformance in earnings generation. Revenue growth of -11.7% contrasts sharply with industry median growth of 13.2%, placing the company in the bottom quartile of growth performance. Financial health metrics show equity ratio of 56.8% above the industry median of 43.9%, suggesting a more conservative capital structure, while current ratio of 217.3% significantly exceeds median 187.0%, reflecting strong liquidity buffers. Asset efficiency shows asset turnover of 0.262 above industry median of 0.17, though this is influenced by the specific asset intensity of peer composition. Working capital metrics reveal substantial operational inefficiencies: inventory turnover days and receivables turnover days of 272 are elevated, though some industry peers also show extended cycles (median inventory days 497.78, median receivables days 269.27). The company's inventory buildup appears more acute than typical seasonal patterns, suggesting company-specific challenges rather than sector-wide trends. Financial leverage of 1.76x is below industry median of 2.23x, consistent with the higher equity ratio and low debt usage. Overall, the company ranks in the lower tier for profitability and growth within the manufacturing sector, with financial health metrics providing some offsetting strength but operational efficiency requiring urgent improvement.
※ Industry: Manufacturing (8 companies), Comparison: FY2025 Q1 period, Source: Proprietary analysis
First, the transition from marginal profitability to operating losses marks a significant inflection point requiring operational restructuring. Revenue contraction of 11.7% combined with SG&A deleverage expanding the cost ratio by 2.4pt indicates fixed cost structure is not aligned with current demand levels. Management's ability to reduce SG&A in absolute terms and restore operating leverage will determine near-term recovery prospects.
Second, the 63.2% surge in inventories to 17.5B yen against declining sales represents a critical working capital management failure. This buildup consumes cash, increases obsolescence risk, and suggests either demand forecasting errors or channel disruptions. Inventory normalization through enhanced sell-through or production curtailment is essential for cash flow recovery and validating asset quality. The extended inventory and receivables turnover days significantly exceed best-in-class peers, indicating structural inefficiencies in supply chain and credit management.
Third, full-year guidance implies an aggressive recovery trajectory that appears disconnected from Q1 results. Achieving 191.0B yen revenue and 8.2B yen operating profit requires sequential quarterly improvement far exceeding historical patterns. Investors should view guidance as aspirational pending evidence of demand recovery, cost actions, and inventory monetization in Q2 results. The substantial gap between Q1 performance and full-year targets creates elevated risk of guidance revision, which would likely pressure valuations further.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.